Today on Outsourcing-Pharma.com   Discovery Labs finally sorts out manufacturing issues Indian clinical research: benefits and challenges 'In-house' outsourcing firm in line for EU accolade FDA told its safety monitoring of clinical trials not good enough Drug theft costs industry up to $1bn a year

Related Industry News   Mitsubishi/Tanabe merger makes Japan's fifth biggest drugmaker BMS shows off cancer drug as it waits for regulator decision Biogen antibody regenerates MS nerves One in the eye for systemic therapy

Breaking News on Outsourcing Pharma
Daily  Tuesday 02 October 2007		Forward to a colleague

	Sponsored Link Introducing Catalent Pharma Solutions Catalent Pharma Solutions is the leading provider of advanced technologies as well as development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer health companies in nearly 100 countries... Click Here Access Full Stories Discovery Labs finally sorts out manufacturing issues Discovery Laboratories could see the end of its struggle to launch its Surfaxin (lucinactant) drug on the US market as it has finally resolved the manufacturing issues that have plagued the product for months... Read Indian clinical research: benefits and challenges Outsourcing-Pharma.com explores the three main benefits and challenges of conducting clinical research in India... Read 'In-house' outsourcing firm in line for EU accolade Synergy has been short-listed in three categories for the upcoming European Outsourcing Awards - an accolade that could give a boost to its innovative "in house" outsourcing model... Read FDA told its safety monitoring of clinical trials not good enough The US Food and Drug Administration (FDA) has been called into question again after the release of a damning report, this time suggesting the agency is inadequate in its safety monitoring of clinical trials... Read Drug theft costs industry up to $1bn a year Pharmaceutical companies not only have to face the consequences of a burgeoning counterfeit drug black market but have to contend with the theft of their own manufactured drugs for illicit uses, according to a... Read
	All News Headlines for: October | September | August
	Company Profile DPT - The Industry Source for Semi-solids and Liquids. DPT is a contract development and manufacturing organization (CDMO) specializing in semi-solid and liquid dosage forms providing solutions from concept to commercialization. Click here to meet with DPT at CPhI/ICSE... Click Here
	Related Industry News Mitsubishi/Tanabe merger makes Japan's fifth biggest drugmaker The marriage of Mitsubishi Tanabe creates a new entity looking to expand its presence outside Japan and create a more efficient R&D and manufacturing machine... Read BMS shows off cancer drug as it waits for regulator decision With a regulator decision looming ever closer, Bristol-Myers Squibb (BMS) has set out to woo European oncologists with its first-in-class breast cancer drug... Read Biogen antibody regenerates MS nerves Biogen Idec is pushing forward with a therapeutic antibody that can turn myelin producing cells back on and so could reverse the damaging effects of multiple sclerosis (MS)... Read One in the eye for systemic therapy TheraKine and Capsulution NanoScience are collaborating to develop new drug delivery systems to aid in the treatment of serious eye diseases... Read Inside India: special series Clinical trials in India: 'The wind is blowing' An industry veteran gives Outsourcing-Pharma.com an update on the state of the contract research organisation (CRO) industry in India. Read Previous Headlines Contract manufacturing news in brief Baxter, LifeCyte, arGentis and Pfizer CentreSource have all recently announced new contract manufacturing deals... Read DSM accelerates its new image DSM has announced the conclusions for the company's complete overhaul as it accelerates the shift to a life sciences and materials sciences company... Read Pfizer's Nigerian court trial over Trovan scandal to kick off Pfizer will appear this week in a Nigerian court to face allegations that it caused the death of Nigerian children over a decade ago when it conducted a clinical trial of its meningitis drug Trovan (trovafloxacin)... Read Novo Nordisk relocates data management from Singapore to India Novo Nordisk is in the process of relocating its clinical data management centre to India after closing down the operation in Singapore, where it had been previously run for many years... Read Pfizer looks to new delivery systems to boost Exubera Pfizer has started development on two next generation inhalers with the aim of replacing the underperforming Exubera inhaled insulin device... Read Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analytical testing, QC Bulk ingredients Contract sales & marketing Data management Drug delivery, formulation Fill & finish, packaging Phase I-II Phase III-IV Preclinical Product & Supplier News - Contract Manufacturing Regulatory affairs Supply chain, logistics Validation services

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@outsourcing-pharma.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com